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Introduction {#sec1}
============

The vitamin D hormone is a major endocrine system with pleiotropic functions ([@bib3]). Physiologically, the majority of the body\'s vitamin D content is derived from photosynthesis in the skin following UV irradiation, and thus body\'s vitamin D levels are influenced by geographic locations, seasonal changes, and skin pigmentations ([@bib13], [@bib14]). Vitamin D is converted to the active hormone 1,25-dihydroxyvitamin D (1,25(OH)~2~D~3~) by two steps of hydroxylation: 25-hydroxylation in the liver followed by 1α-hydroxylation in the kidney ([@bib12]). Cyp27b1 (25-hydroxyvitamin D 1α-hydroxylase) is the rate-limiting enzyme required for the synthesis of 1,25(OH)~2~D~3~. The biological activities of 1,25(OH)~2~D~3~ is mediated by the vitamin D receptor (VDR), a nuclear hormone receptor ([@bib10]). The gut is one of the tissues in the body that have the most abundant VDR expression ([@bib43]), indicating that it is a major physiological target of vitamin D. It is long established that vitamin D/VDR signaling regulates duodenal transcellular calcium transport ([@bib18]). Recent studies demonstrated that gut epithelial VDR plays a key role in protecting the mucosal barrier integrity ([@bib11], [@bib21]). However, little is known about the effect of vitamin D/VDR signaling on the immune components of the gut, including the gut innate immunity.

Innate lymphoid cells (ILCs) are a set of newly discovered innate immune cells emerging as crucial effectors of innate immunity in diverse physiological functions including host defense against infection, tissue remodeling, and maintenance of mucosal barrier integrity ([@bib1], [@bib2]). The diverse populations of ILC family are characterized by a classic lymphoid cell morphology that lacks expression of somatically rearranged antigen receptors and lineage surface markers characteristic of myeloid origin or adaptive immune system; as such, ILCs do not exhibit any degree of antigen specificity and are lineage marker-negative cells ([@bib1]). ILCs are derived from an Id2-dependent common lymphoid progenitor cell population and require interleukin (IL)-7 for their maintenance. ILCs can be grouped based on the transcription factors required for their development and function, and currently there are three major groups: T-bet^+^ ILC (Group 1, ILC1), GATA3^+^ ILC (Group 2, ILC2), and RORγt^+^ ILC (Group 3, ILC3) ([@bib1], [@bib37]).

RORγt^+^ ILC3 is the major ILC in the gut that predominantly produces IL-22 and IL-17 and plays critical roles in protective immunity against bacteria ([@bib37]). It is known that IL-22 stimulates epithelial cells to secret anti-microbial peptides, including RegIIIγ, lipocalin-2, and β-defensins, to constrain pathogenic bacterial growth ([@bib44], [@bib45]). IL-22 also induces mucin expression and colonic epithelial cell proliferation to maintain the integrity of the mucosal barrier ([@bib40]). ILC3 is heterogeneous in mice and humans. In mice, two subsets can be distinguished based on the expression of chemokine receptor CCR6. CCR6^+^ ILC3 include CD4^+^ and CD4^-^ lymphoid tissue inducer (LTi) cells, namely, LTi4 and LTi0, and CCR6^-^ ILC3 encompass cells that express natural cytotoxicity receptor NKp46, namely, NKp46^+^ (or NK22) cells. The development of ILC3 is regulated by a number of nuclear hormone receptors, including RORγt^+^, RARα, and AHR ([@bib1], [@bib29], [@bib34], [@bib39]). Moreover, the development of ILC2 and ILC3 in the gut is deeply influenced by micronutrients such as vitamin A ([@bib39]).

Vitamin D as a micronutrient is well known for its immune-modulatory activity ([@bib9], [@bib23]). A body of research has demonstrated the importance of vitamin D in the regulation of classic innate immune cells (e.g., monocytes, macrophages, dendritic cells) ([@bib20], [@bib26]) and adaptive immune cells (e.g., T~H~1, T~H~17, T~reg~, B cells) ([@bib15], [@bib19], [@bib23], [@bib27], [@bib31], [@bib36], [@bib42]); however, few studies have directly assessed the role of the vitamin D/VDR signaling in ILC biology. Here we present evidence to demonstrate that this signaling pathway is an important regulator of ILC3 development and is required for ILC3-mediated innate immunity in the gut.

Results {#sec2}
=======

Reduced Colonic ILC3 Populations in VDR^−/−^ Mice {#sec2.1}
-------------------------------------------------

Our interest in ILC3 initially derived from an observation that gut ILC3 expressed a high level of VDR. We quantified by qRT-PCR the baseline *Vdr* transcript level in colonic ILC3 (CD3^−^CD90^hi^CD45^lo^) ([@bib8]) and T~H~17 cells (CD3^+^CD4^+^TCRβ^+^GFP(RORγt)^+^) that were sorted from colonic lamina propria (LP) cells by fluorescence-activated cell sorting (FACS) and found that ILC3 *Vdr* transcript was higher compared with sorted T~H~17 cells or purified intestinal epithelial cells ([Figure S1](#mmc1){ref-type="supplementary-material"}), suggesting a role of VDR in ILC3 biology. To address whether VDR regulates ILC3, we compared the colonic mucosal profiles of ILC3 and the sub-populations between VDR^−/−^ and wild-type (WT) mice by FACS analyses (see [Figure S2](#mmc1){ref-type="supplementary-material"} for the gating strategy). The FACS data showed that RORγt^+^ ILC3 ([Figures 1](#fig1){ref-type="fig"}A and 1D), as well as NKp46^+^ ([Figures 1](#fig1){ref-type="fig"}B and 1E), LTi4, and LTi0 ([Figures 1](#fig1){ref-type="fig"}C and 1F) subsets, were all markedly decreased in VDR^−/−^ mice at steady state compared with WT mice, independent of sexes.Figure 1Global VDR Deletion Impairs Gut ILC3 Development in MiceColonic lamina propria (LP) cells were isolated from WT and VDR^−/−^ mice, and the cells were analyzed by FACS for ILC3 populations.(A--C) Representative FACS plots for analysis of RORγt^+^ILC3 (A), NKp46^+^ cells (B), and LTi4 and LTi0 cells (C) in WT and VDR^−/−^ mice at steady state.(D--F) Quantitation based on FACS data of RORγt^+^ILC3 (D), NKp46^+^ cells (E), and LTi4 and LTi0 cells (F) in WT and VDR^−/−^ mice. The data were presented as percentage of the gated population and absolute cell number. \*\*p \< 0.01; \*\*\*p \< 0.001. n = 4 each genotype. Data are represented as mean ± SEM.

To eliminate the potential confounding influence of T and B lymphocytes on ILC3 in the context of VDR ablation, we generated Rag1^−/−^VDR^+/+^ and Rag1^−/−^VDR^−/−^ mice that lacked mature T and B lymphocytes ([@bib22]). FACS analyses confirmed that the colonic CD3^−^RORγt^+^ ILC3 population, as well as LTi4 and LTi0 subsets, but not NKp46^+^ cells, remained reduced in Rag1^−/−^VDR^−/−^ mice compared with Rag1^−/−^VDR^+/+^ controls ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3F), indicating that the effect of VDR deletion on gut ILC3 abundance, particularly the LTi4 and LTi0 cells, is completely independent of T and B cells.

In contrast to gut RORγt^+^ T cells (e.g., T~H~17), the development of gut RORγt^+^ ILC3 is pre-programmed and does not require gut commensal bacteria ([@bib34]). To address whether gut commensal bacteria affects gut ILC3 in the absence of VDR, we depleted gut microbiota from WT and VDR^−/−^ mice by 4-week antibiotic treatment as described previously ([@bib24], [@bib30]). Fecal bacterial 16S rRNA gene was almost undetectable by PCR following antibiotic treatment, confirming that the antibiotics had effectively depleted gut bacteria ([Figure S4](#mmc1){ref-type="supplementary-material"}A). FACS data showed that colonic ILC3 profiles, including CD3^−^RORγt^+^ ILC3 and the NKp46^+^, LTi4 and LTi0 subpopulations, remained suppressed in VDR^−/−^ mice compared with WT controls in the context of the microbiota depletion ([Figures S4](#mmc1){ref-type="supplementary-material"}B--S4G), suggesting that VDR regulation of gut ILC3 is independent of the commensal bacteria.

VDR^−/−^ Mice Develop Impaired Immunity against *Citrobacter rodentium* {#sec2.2}
-----------------------------------------------------------------------

To assess the immunological implication of gut ILC3 reduction in VDR^−/−^ mice, we analyzed their immune response to *Citrobacter rodentium* infection, a model widely used to assess ILC3-mediated immunity ([@bib17]). Following oral gavage of *C*. *rodentium*, VDR^−/−^ mice showed marked weight loss compared with WT mice ([Figure 2](#fig2){ref-type="fig"}A), and about 40% VDR^−/−^ mice died during the infection course (about 30% died within 5 days post infection) ([Figure 2](#fig2){ref-type="fig"}B). We quantified fecal *C*. *rodentium* using MacConkey agar plates ([@bib4]), on which *C*. *rodentium* colonies formed distinctive morphology characterized by a pink center with white rim ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Furthermore, we also validated the identity of *C*. *rodentium* by PCR amplification of the virulence *eae* gene, which is DBS100 strain specific ([@bib28], [@bib35]) ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Following infection, the fecal *C*. *rodentium* counts increased daily before reaching the peak by day 7, followed by bacterial clearance. The peak bacterial count of VDR^−/−^ mice was \>4 times higher compared with that of WT mice. In fact, in VDR^−/−^ mice the increase in fecal bacterial loads was one to two order of magnitude higher each day before reaching the peak, yet the bacterial clearance rate was substantially slower in comparison with WT counterparts ([Figure 2](#fig2){ref-type="fig"}C). FACS analyses detected a robust ILC3 response in WT mice, as total ILC3 population as well as IL-22^+^ILC3, NKp46^+^, LTi4, and LTi0 subsets were all markedly increased on day 5 after *C*. *rodentium* infection ([Figures 2](#fig2){ref-type="fig"}D--2J). In contrast, VDR^−/−^ mice showed a clearly impaired ILC3 response; the induction of ILC3, IL-22^+^ILC3, NKp46^+^, LTi4, and LTi0 cells were all markedly attenuated ([Figures 2](#fig2){ref-type="fig"}D--2J). Particularly, IL-22^+^ ILC3 was almost not induced ([Figures 2](#fig2){ref-type="fig"}E and 2H). Thus, impaired ILC3 response, particularly attenuated IL-22 production, is likely the cause for the dramatic increase in bacterial growth in the gut of VDR^−/−^ mice leading to their high mortality.Figure 2Global VDR Deletion Leads to Impaired Gut Immunity against *C*. *rodentium*WT and VDR^−/−^ mice were gavaged with *C*. *rodentium*. The mice were monitored daily for 16 days post infection. The mice were killed on day 5 following infection for FACS analyses of colonic LP cells.(A--C) (A) Body weight changes (n = 10), (B) survival curve (n = 10--11), and (C) fecal daily bacterial counts (CFU) per gram of feces in WT and VDR^−/−^ mice under *C*. *rodentium* infection (n = 6--7). p \< 0.001 by log rank test.(D--G) Representative FACS plots for the analysis of RORγt^+^ILC3 (D), IL-22^+^ILC3 (E), NKp46^+^ (F), and LTi4 and LTi0 cells (G) in WT and VDR^−/−^ mice at steady state (Ctrl) and under *C*. *rodentium* infection.(H--J) Quantitation RORγt^+^ILC3 and IL-22^+^ILC3 (H), NKp46^+^ cells (I), and LTi4 and LTi0 cells (J) in WT and VDR^−/−^ mice at baseline and under *C*. *rodentium* infection. The data were presented as percentage of the gated population and absolute cell number. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001. n = 4 each group. Data are represented as mean ± SEM.

Deficiency in 1,25(OH)~2~D~3~ Impairs Gut ILC3 Development and ILC3-Mediated Immunity {#sec2.3}
-------------------------------------------------------------------------------------

Cyp27b1^−/−^ mice are completely deficient in 1,25(OH)~2~D~3~ production, as they carry a genetic deletion in the 1α-hydroxylase gene ([@bib25]), the rate-limiting enzyme required for 1,25(OH)~2~D~3~ biosynthesis. To assess whether the regulatory effect of VDR on ILC3 is ligand dependent, we compared the colonic ILC3 profiles between WT and Cyp27b1^−/−^ mice at steady state and under *C*. *rodentium* infection. FACS analyses revealed marked decreases in CD3^−^RORγt^+^ ILC3 populations at the steady state in Cyp27b1^−/−^ mice compared with WT mice ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B, and [Figures 3](#fig3){ref-type="fig"}C--3I). When infected with *C*. *rodentium*, Cyp27b1^−/−^ mice displayed much more severe body weight loss ([Figure 3](#fig3){ref-type="fig"}A) and higher fecal bacterial loads on days 2 and 5 ([Figure 3](#fig3){ref-type="fig"}B). FACS analyses showed that ILC3-mediated immunity was clearly impaired in Cyp27b1^−/−^ mice. On day 5 after infection, ILC3 responses, including the increase in CD3^−^RORγt^+^ ILC3, NKp46^+^, LTi4, and LTi0 cells, were all markedly attenuated in Cyp27b1^−/−^ mice compared with WT controls ([Figures 3](#fig3){ref-type="fig"}C--3I). Importantly, the induction of the IL-22^+^ILC3 population was severely compromised in Cyp27b1^−/−^ mice ([Figures 3](#fig3){ref-type="fig"}D and 3G). These data are similar to those of the ILC3 phenotype seen in VDR^−/−^ mice, indicating that either VDR deletion or VDR ligand deficiency can lead to gut ILC3 deficiency and impaired ILC3-mediated immunity.Figure 3Deficiency in 1,25(OH)~2~D~3~ Synthesis Impairs ILC3 Development and Its Immunity against *C*. *rodentium*WT and Cyp27b1^−/−^ mice were gavaged with *C*. *rodentium*. The mice were killed on day 5 following infection for FACS analyses of colonic LP cells.(A and B) (A) Body weight changes; (B) fecal bacterial counts per gram of feces in WT and Cyp27b1^−/−^ mice on days 2 and 5 following *C*. *rodentium* infection. \*\*\*p \< 0.001 vs. WT. n = 4--5 each group.(C--F) Representative FACS plots for the analysis of RORγt^+^ILC3 (C), IL-22^+^ILC3 (D), NKp46^+^ (E), and LTi4 and LTi0 cells (F) in WT and Cyp27b1^−/−^ mice at steady state (Ctrl) and under *C*. *rodentium* infection.(G--I) Quantitation RORγt^+^ILC3 and IL-22^+^ILC3 (G), NKp46^+^ cells (H), and LTi4 and LTi0 cells (I) in WT and Cyp27b1^−/−^ mice at baseline and under *C*. *rodentium* infection.The data were presented as percentage of the gated population and absolute cell number. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001. n = 4 each group. Data are represented as mean ± SEM.

To confirm that 1,25(OH)~2~D~3~ is required for ILC3 development, we reconstituted Cyp27b1^−/−^ mice with 1,25(OH)~2~D~3~ through daily intraperitoneal injection for one week. FACS analyses showed that 1,25(OH)~2~D~3~ reconstitution was able to partially correct gut ILC3 deficiency in Cyp27b1^−/−^ mice. The total ILC3 population was substantially recovered following 1 week of 1,25(OH)~2~D~3~ injection. Specifically, LTi4 and LTi0 subsets, but not NKp46^+^ cells, were partially increased by 1,25(OH)~2~D~3~ treatment ([Figure S7](#mmc1){ref-type="supplementary-material"}). Therefore, both 1,25(OH)~2~D~3~ and VDR are required for normal ILC3 development and function in the gut, especially for the LTi cells.

Critical Roles of ILC3-intrinsic VDR Signaling in the Regulation of ILC3 {#sec2.4}
------------------------------------------------------------------------

The effect of global VDR deletion in VDR^−/−^ mice on ILC3 could be influenced by many confounding factors in the body. To specifically delineate the role of ILC3-intrinsic VDR signaling in ILC3 regulation, we generated VDR^flox/flox^;RORγt-Cre mice that carried VDR deletion in ILC3. VDR^flox/flox^;RORγt-Cre mice showed a marked and significant reduction in steady-state colonic CD3^−^RORγt^+^ILC3 population compared with VDR^flox/flox^ mice ([Figures 4](#fig4){ref-type="fig"}C and 4G). The baseline IL-22^+^ILC3 population was slightly higher, which may reflect an intrinsic feedback mechanism to maintain IL-22 expression ([Figures 4](#fig4){ref-type="fig"}D and 4G). Specifically, the LTi4 and LTi0 subsets, but not NKp46^+^ cells, were significantly decreased in VDR^flox/flox^;RORγt-Cre mice at the steady state ([Figures 4](#fig4){ref-type="fig"}E, 4F, 4H, and 4I), confirming a critical role of ILC3-intrinsic VDR in the basal development of ILC3, particularly the LTi subsets. When VDR^flox/flox^ and VDR^flox/flox^;RORγt-Cre mice were infected with *C*. *rodentium*, VDR^flox/flox^;RORγt-Cre mice showed more severe body weight loss and much higher fecal bacterial counts on day 4 compared with VDR^flox/flox^ mice ([Figures 4](#fig4){ref-type="fig"}A and 4B). ILC3 responses, including the increases in CD3^−^RORγt^+^ ILC3 and LTi4 and LTi0 subsets (not NKp46^+^) were markedly attenuated in VDR^flox/flox^;RORγt-Cre mice ([Figures 4](#fig4){ref-type="fig"}C--4I). Particularly, the IL-22^+^ILC3 population failed to be induced in VDR^flox/flox^;RORγt-Cre mice ([Figures 4](#fig4){ref-type="fig"}D and 4G). Thus, ILC3-intrinsic VDR deletion impairs the ILC3 baseline development as well as ILC3-mediated immunity, indicating a critical role of ILC3-intrinsic vitamin D/VDR signaling in ILC3 biology.Figure 4ILC3-specific Deletion of VDR Impairs ILC3 Development and Its Immunity against *C*. *rodentium* InfectionVDR^flox/flox^ and VDR^flox/flox^;RORγt-Cre mice were gavaged with *C*. *rodentium.* The mice were killed on day 4 following infection.(A and B) (A) Body weight changes; (B) fecal bacterial counts per gram of feces in VDR^flox/flox^ and VDR^flox/flox^;RORγt-Cre mice on day 4 after *C*. *rodentium* infection. \*\*\*p \< 0.001 vs. VDR^flox/flox^. n = 4--5 each genotype.(C--F) Representative FACS plots for the analysis of RORγt^+^ILC3 (C), IL-22^+^ILC3 (D), NKp46^+^ (E), and LTi4 and LTi0 cells (F) in VDR^flox/flox^ and VDR^flox/flox^;RORγt-Cre mice at steady state (Ctrl) and under *C*. *rodentium* infection.(G--I) Quantitation RORγt^+^ILC3 and IL-22^+^ILC3 (G), NKp46^+^ cells (H), and LTi4 and LTi0 cells (I) in VDR^flox/flox^ and VDR^flox/flox^;RORγt-Cre mice at baseline and under *C*. *rodentium* infection.The data were presented as percentage of the gated population and absolute cell number. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001. n = 4 each group. Data are represented as mean ± SEM.

RORγt is the master transcription factor in ILC3 and T~H~17 lineages, but it may also express in other tissues; as such, RORγt-Cre could be leaky to other cells/tissues. To confirm that it was VDR deletion in ILC3 that led to ILC3 defects, we transplanted Rag1^−/−^ mice with bone marrow (BM) cells obtained from VDR^flox/flox^ or VDR^flox/flox^;RORγt-Cre mice using procedures as previously reported ([@bib41]). The success of the BM transplantation was validated in a parallel control experiment in which CD45.2 VDR^−/−^ BM cells were transplanted to CD45.1 recipient mice ([Figure S8](#mmc1){ref-type="supplementary-material"}). As shown in [Figure S8](#mmc1){ref-type="supplementary-material"}, 8 weeks after transplantation, CD45.2^+^ cells repopulated the blood and colonic lamina propria of the CD45.1 recipients. Importantly, the recipient\'s RORγt^+^ cells (which include ILC3) were now CD45.2^+^. Interestingly, 8 weeks after transplantation, Rag1^−/−^ mice receiving VDR^flox/flox^;RORγt-Cre BM cells still had significantly lower CD3^−^RORγt^+^ILC3 population as well as lower LTi4 and LTi0 subpopulations compared with Rag1^−/−^ mice receiving VDR^flox/flox^ BM cells ([Figures 5](#fig5){ref-type="fig"}A and 5B). These results confirmed that the ILC3-intrinsic VDR signaling indeed directly regulates ILC3 development, particularly the LTi subsets.Figure 5Bone Marrow (BM) Transplantation Confirms VDR Deletion in ILC3 Leading to Impaired ILC3 DevelopmentBM cells obtained from VDR^flox/flox^ or VDR^flox/flox^/RORγt-Cre mice were transplanted to recipient Rag1^−/−^ mice 6 h after receiving lethal γ-irradiation. The recipient mice were analyzed 8 weeks after transplantation.(A and B) (A) Representative FACS plots for RORγt^+^ILC3 analyses; (B) quantitation of colonic RORγt^+^ILC3, NKp46^+^, and LTi4 and LTi0 cells in recipient mice transplanted with VDR^flox/flox^ or VDR^flox/flox^;RORγt-Cre BM cells. The data were presented as percentage of the gated population and absolute cell number. \*p \< 0.05, \*\*p \< 0.01. n = 3--4 each group. Data are represented as mean ± SEM.

Vitamin D/VDR Signaling Regulates ILC3 Proliferation {#sec2.5}
----------------------------------------------------

To address how vitamin D/VDR signaling regulates ILC3 development, we assess the effect of VDR deletion on ILC3 apoptosis and proliferation, two processes that potentially determine the abundance of gut ILC3. To assess ILC3 apoptosis, we generated VDR^−/−^Rorc^gfp/+^ mice whose ILC3 is marked by GFP. FACS analyses found no differences between VDR^+/+^Rorc^gfp/+^ and VDR^−/−^Rorc^gfp/+^ mice in Annexin V^+^/7-AAD^+^ and Annexin V^+^/7-AAD^-^ cells among all the gut ILC3 populations ([Figure S9](#mmc1){ref-type="supplementary-material"}), suggesting that ILC3 defects caused by VDR deletion is not due to excessive ILC3 apoptosis. We then quantified ILC3 proliferation by Ki67 staining. Remarkably, Ki67^+^ cells in the CD3^−^RORγt^+^ILC3 population as well as in LTi4 and LTi0 subsets were clearly decreased at steady state in VDR^−/−^ mice ([Figures 6](#fig6){ref-type="fig"}A and 6B), VDR^flox/flox^;RORγt-Cre mice ([Figures 6](#fig6){ref-type="fig"}C and 6D), and Cyp27b1^−/−^ mice ([Figures 6](#fig6){ref-type="fig"}E and 6F) compared with VDR^+/+^ mice, VDR^flox/flox^ mice, and Cyp27b1^+/+^ mice, respectively. Under *C*. *rodentium* infection, the Ki67^+^ ILC3 cells, including CD3^−^RORγt^+^ cells and LTi4 and LTi0 subsets, were dramatically induced in VDR^+/+^ mice and VDR^flox/flox^ mice, but the induction was greatly attenuated in VDR^−/−^ mice and VDR^flox/flox^;RORγt-Cre mice ([Figures 6](#fig6){ref-type="fig"}A--6D). In these three mouse models, however, there were almost no changes in Ki67^+^NKp46^+^ cells ([Figures 6](#fig6){ref-type="fig"}A--6F). These observations suggest that the vitamin D/VDR signaling plays a key role in the regulation of gut ILC3 expansion, mainly the LTi cells.Figure 6Deletion of VDR or Cyp27b1 Reduces ILC3 ProliferationColonic LP cells were isolated from WT or VDR^−/−^ mice at steady state (Ctrl) or under *C*. *rodentium* infection for 5 days (A and B), from VDR^flox/flox^ or VDR^flox/flox^;RORγt-Cre mice at steady state or under *C*. *rodentium* infection for 5 days (Cand D), or from WT and Cyp27b1^−/−^ mice at steady state (E and F). Ki67^+^ ILC3 and ILC3 subsets were quantified by FACS. (A, C, and E) Representative FACS plots for Ki67^+^ RORγt^+^ILC3; (B, D, and F) quantitation of Ki67^+^RORγt^+^ILC3 and Ki67^+^NKp46^+^, Ki67^+^LTi4, and Ki67^+^LTi0 subsets. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001. n = 4--5 each group. Data are represented as mean ± SEM.

To confirm this notion, we further examined the effect of VDR activation by its ligand on ILC3 proliferation. As shown in [Figure 7](#fig7){ref-type="fig"}, reconstitution of Cyp27b1^−/−^ mice with 1,25(OH)~2~D~3~ by 1-week daily injection was able to mostly restore the Ki67^+^ ILC3 populations (CD3^−^RORγt^+^, LTi4, LTi0) in the colonic mucosa ([Figure 7](#fig7){ref-type="fig"}A). Moreover, daily treatment of WT mice with a low calcemic vitamin D analogue, paricalcitol, for 1 week was able to substantially stimulate colonic Ki67^+^ ILC3 populations (CD3^−^RORγt^+^, LTi4 and LTi0) ([Figure 7](#fig7){ref-type="fig"}B). Consistently, there were little effects from these treatments on Ki67^+^ NKp46^+^ cells ([Figures 7](#fig7){ref-type="fig"}A and 7B).Figure 7Ligand Activation of VDR Stimulates ILC3 Proliferation(A) FACS quantitation of colonic Ki67^+^RORγt^+^ILC3 and Ki67^+^NKp46^+^, Ki67^+^LTi4, and Ki67^+^LTi0 subpopulations in WT, Cyp27b1^−/−^ or Cyp27b1^−/−^ mice treated with 1,25(OH)~2~D~3~ for 1 week; (B) FACS quantitation of colonic Ki67^+^RORγt^+^ILC3 and Ki67^+^NKp46^+^, Ki67^+^LTi4, and Ki67^+^LTi0 subsets in WT untreated or treated with paricalcitol for 1 week; (C) Lin^−^Thy1.2^hi^KLRG1^−^IL-7Rα^+^ cells were sorted by FACS and cultured in the presence or absence of 1,25(OH)~2~D~3~ for 3 days, and Ki67^+^RORγt^+^ILC3 population was analyzed by FACS. Shown are representative FACS plots. \*p \< 0.05, \*\*p \< 0.01; \*\*\*p \< 0.001. n = 4 each group. Data are represented as mean ± SEM.

To address whether vitamin D/VDR signaling directly regulates ILC3 proliferation, we FACS-sorted Lin^−^Thy1.2^hi^KLRG1^−^IL-7Rα^+^ cells from colonic LP cells from Rag1^−/−^ mice as described previously ([@bib39]) (see [Figure S10](#mmc1){ref-type="supplementary-material"} for the sorting strategy) and then cultured these cells for 3 days in a medium containing IL-7 and stem cell factor (SCF) in the presence or absence of 1,25(OH)~2~D~3~ before quantifying the Ki67^+^ ILC3 population by FACS. We found that 1,25(OH)~2~D~3~ treatment was able to increase the Ki67^+^RORγt^+^ cell population by \>56% *in vitro* ([Figure 7](#fig7){ref-type="fig"}C). This is compelling evidence demonstrating that the vitamin D/VDR signaling indeed directly stimulates ILC3 proliferation.

Discussion {#sec3}
==========

In this report we presented several lines of evidence to demonstrate that the vitamin D/VDR signaling pathway critically regulates ILC3 development and function in the gut. We showed that VDR deletion caused a marked reduction in gut ILC3 populations and compromises ILC3-mediated innate immunity against bacterial infection. This regulatory action of VDR on ILC3 is independent of T and B lymphocytes and gut commensal bacteria. We also showed that the deficiency of 1,25(OH)~2~D~3~, the VDR ligand, basically phenocopied VDR deficiency in terms of affecting gut ILC3 development and function, indicating that the regulatory action of VDR on ILC3 is ligand dependent. Given that the majority of VDR actions is known to be dependent on 1,25(OH)~2~D~3~, the similar ILC3 phenotypes seen in VDR^−/−^ and Cyp27b1^−/−^ mice actually provide a strong confirmation for the reliability of our findings. By specifically deleting VDR from ILC3 we further demonstrated that the ILC3-intrisinc VDR signaling is required for normal development and function of ILC3. Our data suggest that promoting ILC3 proliferation and differentiation is an important mechanism whereby the vitamin D/VDR signaling regulates ILC3. Together these findings extend our understanding of the immunoregulatory activities of the vitamin D/VDR signaling in innate immunity.

Although it is well established that the vitamin D endocrine system regulates immune responses ([@bib9], [@bib23]), few studies have explored the effect of vitamin D and VDR on innate lymphoid cells. A previous study by Chen et al. reported that global VDR deletion caused dysbiosis, which conferred resistance to *C*. *rodentium* infection to VDR knockout mice because of increased ILC3 and antimicrobial peptides; however, elimination of gut microbiota with antibiotics rendered VDR knockout mice more susceptible to *C*. *rodentium* than control mice. These findings are inconsistent with our results. However, this same study also showed that elimination of T and B lymphocytes from VDR knockout mice (Rag1^−/−^VDR^−/−^ mice) increased their susceptibility to *C*. *rodentium* infection when compared with controls ([@bib6]), which is consistent with our findings reported here, confirming the notion that the VDR regulation of ILC3 is independent of functional T and B lymphocytes. This prior report, although interesting, provided no clear answers as to whether and how VDR influences ILC3. Additionally, there are two other reports by Ryz et al. that studied the relationship between vitamin D and *C*. *rodentium* infection but not ILC3. One paper showed that vitamin D deficiency increased mouse\'s susceptibility to *C*. *rodentium* mostly because of increased production of pro-inflammatory cytokines ([@bib32]), and the other showed that 1,25-dihydroxyvitamin D treatment also increased mouse\'s susceptibility to *C*. *rodentium* mostly because of the suppression of T~H~17 response ([@bib33]). Together these unsettled and seemingly contradictory studies provide a strong rationale to explore the roles of the vitamin D/VDR signaling pathway in ILC3 regulation and in *C*. *rodentium* infection. Therefore, in the current study we employed a series of genetic mouse models to tackle these important issues.

As the biological action of the vitamin D endocrine system depends on both the vitamin D hormone and its receptor, we studied genetic models that lack either the receptor (VDR knockout) or the ability to synthesize the vitamin D hormone (Cyp27b1 knockout). We also examined VDR knockout mice that lack mature T and B lymphocytes (Rag1^−/−^/VDR^−/−^ mice) or commensal microflora to eliminate the potentially confounding effects of the adaptive immune system and microbiota on the results. Because VDR knockout mice develop many abnormalities ([@bib3]) that may interfere with data interpretation, we further studied VDR^flox/flox^;RORγt-Cre mice that lack VDR signaling in ILC3 as well as lethally irradiated mice that are repopulated with VDR^flox/flox^;RORγt-Cre bone marrow cells. These cell-specific deletion and bone marrow transplantation models generated compelling evidence for a direct and critical role of VDR in ILC3 biology. In addition to ILC3, RORγt is also expressed in T~H~17 and T~reg~ cells; thus VDR^flox/flox^;RORγt-Cre mice may carry VDR deletion in ILC3 as well as in T~H~17 and T~reg~ cells. However, because we had already demonstrated that VDR deletion in T cells did not influence the effect of VDR on ILC3, particularly the LTi cells (see [Figure S3](#mmc1){ref-type="supplementary-material"}, Rag1^−/−^/VDR^−/−^ mice), the VDR^flox/flox^;RORγt-Cre mice thus allowed us to study and elucidate the intrinsic role of ILC3 VDR in ILC3 regulation. Indeed, the intrinsic stimulatory effect of vitamin D/VDR on ILC3 was confirmed in the *in vitro* ILC3 culture ([Figure 7](#fig7){ref-type="fig"}C). Furthermore, in this study we analyzed not only the CD3^−^RORγt^+^ cells but also the NKp46^+^ and LTi0/4 subsets. The data from these models all firmly support the notion that the vitamin D/VDR signaling is required for the development and anti-bacterial function of gut ILC3. In the absence of 1,25(OH)~2~D~3~ or VDR, gut ILC3 populations markedly decreased and failed to proliferate leading to impaired immunity against *C*. *rodentium*. Particularly, the IL-22-producing ILC3 population failed to expand in response to *C*. *rodentium* infection, which likely accounts for the severe bacterial growth and high mortality seen in the mutant mice, because IL-22 released from LTi4 cells in the first 6 days following *C*. *rodentium* infection is the major IL-22 source to counter the infection ([@bib38]). In fact, the results from all our mouse models, as well as from *in vitro* ILC3 culture, are very consistent to show that the vitamin D/VDR signaling promotes the proliferation of LTi cells, but the effect on NKp46^+^ cells is inconsistent. That is, our data strongly suggest that the mechanism responsible for vitamin D/VDR regulation of ILC3-mediated innate immunity lies in its stimulation of proliferation of LTi0 and LTi4 cells, but not NKp46^+^ cells. Since NKp46^+^ and LTi cells are derived from different precursors ([@bib1]), it is not surprising that the vitamin D/VDR activity has different effects on these cells. In fact, whether vitamin D regulates NKp46^+^ cells or not should not have a meaningful impact on vitamin D-regulated ILC3 immunity, as NKp46^+^ cells or NKp46-derived IL-22 only plays a minor role in innate immunity against *C*. *rodentium* ([@bib5]). Therefore, given the importance of LTi cells, future studies should be focused on how vitamin D/VDR regulates LTi cell proliferation and LTi-mediated immunity.

IL-22 is a key cytokine produced by ILC3 that plays key roles in host defense against infection as well as in tissue remodeling and maintenance of mucosal barrier integrity ([@bib1], [@bib2]). The latter is overlapped with the mucosal barrier-protecting activity of the vitamin D/VDR signaling ([@bib7], [@bib11], [@bib21]). It is conceivable that vitamin D/VDR may also protect the integrity of the mucosal barrier through regulating IL-22 production from ILC3. Here our data suggest that vitamin D/VDR regulates IL-22 synthesis through controlling ILC3 proliferation, but it is also possible that VDR directly regulates IL-22 gene expression, as seen in other nuclear receptors such as RORγt^+^ and AHR ([@bib29], [@bib34]). A most recent study reported that vitamin D/VDR downregulates IL-23 receptor-mediated pathway in human NKp44^+^ ILC3 (mouse NKp46^+^ equivalent), suppressing IL-22 expression ([@bib16]). This *in vitro* observation in human ILC3 appears in contrast to our *in vivo* finding, but it is irrelevant because our studies have shown that vitamin D/VDR has little effects on NKp46^+^ cells in mice. The reason behind the discrepancy between humans and mice in terms of vitamin D regulation of NKp44^+^/NKp46^+^ cells is unclear.

There have been increasing interests in the anti-infectious activity of vitamin D. A good example is a study that demonstrated how vitamin D stimulates anti-microbial activity in macrophages against *Mycobacterium tuberculosis* ([@bib20]). Here we show that vitamin D also stimulates potent innate immunity against *C*. *rodentium* infection via gut ILC3. The results from these investigations suggest that the vitamin D endocrine system has intrinsic anti-infectious and anti-bacterial activity to serve the host defense system. In this regard, maintaining appropriate vitamin D levels in the body is important for an effective host defense against infection.

Limitations of the Study {#sec3.1}
------------------------

In this study we presented strong evidence that the vitamin D/VDR signaling is required for proper proliferation and function of ILC3, particularly the LTi0 and LTi4 cells at baseline and under pathogenic bacterial infection; however, exactly how the vitamin D/VDR signaling regulates ILC3 proliferation remains unclear. Future studies are needed to elucidate the underlying molecular mechanism. Moreover, germ-free models are needed to confirm the effect of gut microbiota on vitamin D regulation of ILC3.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods and Figures S1--S10
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